The global T-Cell lymphoma market is expected to reach USD 3,390.6 million by 2030, at a CAGR of 8.50% during the forecast period 2021 to 2030. The T-Cell lymphoma market has grown due to the increasing number of the geriatric population and the risk of lymphoma due to autoimmune disorders.